Assessment of Third Trimester Post-void Residual and Validation of Bladder Scanner in Pregnancy and Post-partum
This study has been completed.
Information provided by (Responsible Party):
Michael Stitely, West Virginia University
First received: October 29, 2008
Last updated: June 11, 2013
Last verified: June 2013
This will be a descriptive study measuring the post—void residual of patients in the third trimester and postpartum. Also, bladder scan values will be compared to the amount of urine obtained from a Foley catheter to determine the accuracy of the bladder scanner in the third trimester and postpartum.
||Time Perspective: Prospective
||Assessment of Third Trimester Post-void Residual Along With Determining Validity of the Bladder Scanner in the Third Trimester of Pregnancy and Postpartum
Primary Outcome Measures:
- Define normal post-void residual volume in third trimester pregnancy and post-partum. [ Time Frame: 12-24 hours ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Calculate the validity of measurements form the bladder scanner ultrasound for bladder volumes during the third trimester of pregnancy and post-partum. [ Time Frame: 12-24 hours ] [ Designated as safety issue: No ]
| Study Start Date:
| Primary Completion Date:
||December 2009 (Final data collection date for primary outcome measure)
Bladder Scan Group
Patients who agree to enroll in the trial and allow their known bladder volumes and residual bladder volumes to be measured by actual volumes retrograde instilled, and also by bladder scanner ultrasound.
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
All adult patients undergoing elective or non-emergent Cesarean delivery will be asked to enroll. Also adult patients having a labor epidural placed during labor will be asked to participate.
- Age greater than 18 years.
- Having a non-emergent Cesarean Delivery or labor epidural placed.
- Age less than 18 years.
- Emergent Cesarean delivery.
- No epidural labor analgesia.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00782730
|West Virginia University
|Morgantown, West Virginia, United States, 26506 |
West Virginia University
||Michael L Stitely, MD
||West Virginia University
No publications provided
||Michael Stitely, Adjunct Associate Professor, West Virginia University
History of Changes
|Other Study ID Numbers:
|Study First Received:
||October 29, 2008
||June 11, 2013
||United States: Institutional Review Board
Keywords provided by West Virginia University:
ClinicalTrials.gov processed this record on July 30, 2015
bladder volume measurement
Postvoid residual volume assessment